Where we are now
We’re just getting started.
GreenLight Bio’s 13+ years of scientific progress have laid the foundation for major advances in sustainable agriculture—advances that are already reaching growers.
Demonstrated control of fungal pathogens
Our first commercial products, Calantha™ and Norroa™, are already in the hands of growers and beekeepers. Calantha™ establishes a new standard for biological crop protection, while Norroa™ provides honeybee keepers with an RNA‑powered solution to protect colonies from destructive varroa mite pressure. Together, they demonstrate that scalable, field‑ready RNA solutions can deliver reliable performance across diverse agricultural systems.
Calantha™ and Norroa™: Delivering impact today
Protecting pollinators is central to our mission. Field results from our ongoing work show that our bee‑focused RNA tools help improve colony health and brood development when facing varroa mite stress. These outcomes reinforce our commitment to developing products that strengthen pollinator resilience and reduce reliance on harsh chemistries.
Progress for bees
We have demonstrated field‑proven control of fungal pathogens using double‑stranded RNA, including strong performance against powdery mildew, one of the most economically damaging diseases in specialty crops worldwide.
Our powdery mildew product has now been submitted for regulatory review, moving us from field validation into commercial readiness and supporting growers who need cleaner, resistance‑breaking solutions.
A Covid-19 vaccine
Our next-generation mite control product uses a multi‑species dsRNA design that targets an essential gene conserved across numerous herbivorous mite pests in the Tetranychoidea superfamily—a group encompassing over 100 agricultural pest species.
Despite its broad reach, the design remains highly specific, affecting pest mites while sparing beneficial organisms. Importantly, unlike traditional chemical pesticides, this dsRNA‑based solution is compatible with predatory‑mite biocontrol programs, enabling growers to strengthen IPM strategies without disrupting beneficial populations.
This multi‑species mite product has also been submitted for regulatory review, marking a significant step toward delivering next-generation biological control for growers.
Bill & Melinda Gates milestone reached
GreenLight Bio’s platform—backed by foundational patents and more than a decade of technological innovation—enables cost‑efficient production of double‑stranded RNA at unprecedented scale. Our combination of process know‑how, precision design, and technical agility positions us to rapidly develop and deploy a new generation of biological tools that strengthen farms, ecosystems, and global food security.
We are ready for the next phase of growth—and the next wave of products that will follow.
To find out more, click here.